title: Rituximab as a first-line treatment in pediatric neuromyelitis optica spectrum disorder.
authors: Unit of Child Neuropsychiatry, Catholic University, Rome, Italy.
authors: Giorgia
authors: G
authors: Olivieri
authors: Department of Geriatrics, Neurosciences and Orthopedics, Institute of Neurology, Catholic University, Largo A. Gemelli 8, 00168, Rome, Italy. viviana.nociti@rm.unicatt.it.|Don C. Gnocchi Foundation Onlus, Milan, Italy. viviana.nociti@rm.unicatt.it.
authors: Viviana
authors: V
authors: Nociti
authors: Department of Geriatrics, Neurosciences and Orthopedics, Institute of Neurology, Catholic University, Largo A. Gemelli 8, 00168, Rome, Italy.
authors: Raffaele
authors: R
authors: Iorio
authors: Unit of Child Neuropsychiatry, Catholic University, Rome, Italy.
authors: Maria Chiara
authors: MC
authors: Stefanini
authors: Department of Geriatrics, Neurosciences and Orthopedics, Institute of Neurology, Catholic University, Largo A. Gemelli 8, 00168, Rome, Italy.
authors: Francesco Antonio
authors: FA
authors: Losavio
authors: Department of Geriatrics, Neurosciences and Orthopedics, Institute of Neurology, Catholic University, Largo A. Gemelli 8, 00168, Rome, Italy.
authors: Massimiliano
authors: M
authors: Mirabella
authors: Unit of Child Neuropsychiatry, Catholic University, Rome, Italy.
authors: Paolo
authors: P
authors: Mariotti
mesh_terms: D051401:Aquaporin 4 / Q000276:immunology*; D001323:Autoantibodies / Q000276:immunology*; D002648:Child; D005260:Female; D006801:Humans; D009471:Neuromyelitis Optica / Q000175:diagnosis / Q000188:drug therapy*; D000069283:Rituximab / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D051401:Aquaporin 4; D001323:Autoantibodies; D000069283:Rituximab
keywords: Aquaporin-4; First-line therapy; Pediatric NMOSD; Rituximab